These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11224312)

  • 1. Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats.
    Sams-Dodd F
    Behav Pharmacol; 1995 Jan; 6(1):55-65. PubMed ID: 11224312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia.
    Sams-Dodd F
    Behav Pharmacol; 1996 Jan; 7(1):3-23. PubMed ID: 11224390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats.
    Sams-Dodd F
    Neuropsychopharmacology; 1998 Jul; 19(1):18-25. PubMed ID: 9608573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test.
    Sams-Dodd F
    Psychopharmacology (Berl); 1998 Jan; 135(2):182-93. PubMed ID: 9497024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
    Seillier A; Giuffrida A
    Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test.
    Sams-Dodd F
    Behav Pharmacol; 1997 Jun; 8(2-3):196-215. PubMed ID: 9833015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of nitric oxide in social dysfunction.
    Wass C; Klamer D; Fejgin K; Pålsson E
    Behav Brain Res; 2009 Jun; 200(1):113-6. PubMed ID: 19166879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat.
    Liu J; Suzuki T; Seki T; Namba T; Tanimura A; Arai H
    Synapse; 2006 Jul; 60(1):56-68. PubMed ID: 16596623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats.
    Schwabe K; Klein S; Koch M
    Behav Brain Res; 2006 Mar; 168(1):150-60. PubMed ID: 16387372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia.
    Javitt DC
    Hillside J Clin Psychiatry; 1987; 9(1):12-35. PubMed ID: 2820854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.
    Kalinichev M; Robbins MJ; Hartfield EM; Maycox PR; Moore SH; Savage KM; Austin NE; Jones DN
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):414-22. PubMed ID: 17945407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
    Mouri A; Noda Y; Enomoto T; Nabeshima T
    Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of acute amphetamine and phencyclidine treatment and withdrawal from repeated amphetamine or phencyclidine treatment on social interaction and social memory in rats.
    Li M; He W; Munro R
    Psych J; 2012 Jun; 1(1):56-68. PubMed ID: 26272667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia.
    Rung JP; Carlsson A; Rydén Markinhuhta K; Carlsson ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):827-32. PubMed ID: 15916843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline temperature in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration.
    Radonjić NV; Petronijević ND; Vucković SM; Prostran MS; Nesić ZI; Todorović VR; Paunović VR
    Physiol Behav; 2008 Feb; 93(3):437-43. PubMed ID: 17996259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic phencyclidine exposure potentiates the behavioral and c-Fos response to stressful stimuli in rats.
    Turgeon SM; Lin T; Subramanian M
    Pharmacol Biochem Behav; 2007 Nov; 88(1):73-81. PubMed ID: 17698179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine.
    Gozzi A; Schwarz A; Crestan V; Bifone A
    Magn Reson Imaging; 2008 Sep; 26(7):999-1006. PubMed ID: 18486387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats.
    Rodefer JS; Murphy ER; Baxter MG
    Eur J Neurosci; 2005 Feb; 21(4):1070-6. PubMed ID: 15787711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.
    Enomoto T; Noda Y; Nabeshima T
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):291-301. PubMed ID: 17609743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.